Depersonalization: Clinical Trials

6 trials for Depersonalization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 3 Not applicable, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 22Completed 1, Withdrawn 1
Phase 11Completed 1

Follow Depersonalization: new trials by email Literature Review of Depersonalization trials Research Report on Depersonalization

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dissociation CBT Studies
Brief CBT - Dissociation, Depersonalization
Not applicableCompletedUniversity of Birmingham92023-09-202025-07-03
Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation
Active rTMS, Placebo rTMS - Depersonalization Disorder
Not applicableCompletedCentre Hospitalier St Anne812015-06-192023-11-01
Feasibility Trial of CBT for Depersonalisation in Psychosis
CBT for Depersonalization/Derealization, Treatment as usual - Psychotic Disorders, Depersonalization
Phase 1CompletedKing's College London202015-03-012016-08-08
Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)
Daily rTMS with Active coil, Daily rTMS with Sham coil, Open Label Daily rTMS with Active coil - Depersonalization Disorder
Phase 2WithdrawnNew York State Psychiatric Institute2013-10-012017-03-24
Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)
Repetitive Transcranial Magnetic Stimulation (rTMS) - Depersonalization Disorder
Phase 2CompletedNew York State Psychiatric Institute102006-05-012014-09-22
Study of Fluoxetine in Patients With Depersonalization Disorder
fluoxetine - Depersonalization Disorder
Not applicableCompletedNational Institute of Mental Health (NIMH)801998-04-012005-06-24

Narrower conditions

Dissociative Disorders (3)  ·  Behavioral Symptoms (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Psychotic Disorders (1)  ·  Rare Diseases (1)

Broader conditions

Behavior (6)  ·  Behavioral Symptoms (5)  ·  Mental Disorders (4)  ·  Disease Attributes (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Fluoxetine (1)  ·  Therapeutics (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

New York State Psychiatric Institute (2)  ·  Centre Hospitalier St Anne (1)  ·  King's College London (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  University of Birmingham (1)

Countries

United States (3)  ·  United Kingdom (2)  ·  France (1)

Top investigators

Antonio Mantovani, MD (1)  ·  Antonio Mantovani, MD, PhD (1)  ·  Daniel Javitt, MD, PhD (1)  ·  Daphne Simeon (1)  ·  Emma Cernis, DPhil (1)  ·  Marion Plaze, MD, PhD (1)  ·  Simone Farrelly, PhD (1)

Results publications

PMID 27965864, PMID 37716893